Bivalent Covid Shot Should Become Standard, FDA Advisers Say (1)

Jan. 26, 2023, 10:46 PM UTC

Bivalent Covid-19 shots should become the standard form of the vaccine, US advisers said, part of a plan to offer a single booster to the public each year that gives protection against the most recent, dominant strains.

Anyone getting a Covid shot for the first time now receives a vaccine designed in 2020, when the virus looked a lot different than it does today. A panel of 21 advisers to the Food and Drug Administration voted unanimously Thursday to make bivalent vaccines, designed to fight the BA.4 and BA.5 omicron strains, the primary option.

Bivalent shots made by Pfizer Inc. ...



Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.